Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
Recruiting · NCT02938611 · Observational (researchers observe without assigning treatment) · Lead sponsor: Centre Hospitalier Universitaire de Nīmes
View the official record on ClinicalTrials.gov →What this trial is about
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- chronic kidney disease (stage \>= 4)
Where it is running
4 locations listed.
- AIDER - Unité de Dialyse d'Alès - Alès, France
- AIDER - Unité de Dialyse de Nîmes, CHU Carémeau - Nîmes, France
- CHU de Nîmes - Hôpital Universitaire Carémeau - Nîmes, France
- Gardialyse - Nîmes, France